Displaying 46 (all) recruiting clinical trials.
-
A PHASE IB-II STUDY OF HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE BORTEZOMIB AND ABATACEPT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
The purpose of the study is to determine if the administration of the investigational prophylactic medications: PTCy, bortezomib and abatacept, for individuals with hematological malignancies ...
Phase
Interventional
-
MONETTE: A Randomised Open-Label Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresectable or Advanced Melanoma and Primary or Secondary Resistance to PD-(L)1 Inhibition
The purpose of the study is to evaluate the efficacy and safety/tolerability of ceralasertib, when administered alone and in combination with with durvalumab. We ...Phase
Interventional
-
A Phase 2 Open-Label Study to Evaluate Etavopivat for the Treatment of Anemia in Patients with Myelodysplastic Syndromes (MDS).
You can participate in this study if you are diagnosed with Myelodysplastic Syndromes (MDS). In this study we will evaluate the study drug (Etavopivat) for ...Phase
Interventional
-
A Phase II study of Atezolizumab and Bevacizumab in Child-Pugh B7 Hepatocellular Carcinoma.
You can participate in this study if you are diagnosed with advanced liver cancer. The purpose of this study is to determine the efficacy and ...Phase
Interventional
-
A phase II trial of ImmunotheRapy with single fRactIon non-ablative raDIAtion in previously untreated patients with stage IV NSCLC. (IRRIDIATE-Lung trial).
You can participate in this study if you are diagnosed with advanced lung cancer. The primary goal of this trial is to evaluate the efficacy ...Phase
Interventional
-
A Phase II Study of Ribociclib And Endocrine Treatment of Physician s Choice for Locoregional Recurrent Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study).
You can participate in this study if you are diagnosed with Hormone Receptor (HR) positive, HER2 negative breast cancer (Stages I-II). The purpose of this ...Phase
Interventional
